Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy
The Lancet Primary Care · 2026-08 · 2 (8) · 100201
DOI: 10.1016/j.lanprc.2026.100201 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Primary Care, 2026-08. Verfasst von Thijs T Jansz und 5 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation Medical Research Council.
Abstract (Originalsprache)
We thank Dion Groothof and colleagues for their interest in our work.1 The authors raise the possibility that GLP-1 receptor agonists might result in muscle loss and that such body composition changes might influence estimates of the glomerular filtration rate (GFR). We agree that this point warrants consideration when interpreting estimated GFR (eGFR)-based outcomes. We also agree that further mechanistic studies incorporating measured GFR alongside assessments of body composition would help to better characterise the kidney outcomes as a result of incretin-based therapies, both as monotherapy and in combination with SGLT2 inhibitors.
Förderung
- UK Research and Innovation Medical Research Council
Zitieren
APA
Jansz, T. T., Young, K. G., Dinsdale, M. M., Cardoso, P., Oram, R. A., & Dennis, J. M. (2026). Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy. The Lancet Primary Care, 2(8), 100201. https://doi.org/10.1016/j.lanprc.2026.100201
Vancouver
Jansz TT, Young KG, Dinsdale MM, Cardoso P, Oram RA, Dennis JM. Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy. The Lancet Primary Care. 2026;2(8):100201. doi:10.1016/j.lanprc.2026.100201
BibTeX
@article{Jansz2026,
author = {Jansz, Thijs T and Young, Katherine G and Dinsdale, Martha M and Cardoso, Pedro and Oram, Richard A and Dennis, John M},
title = {Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy},
journal = {The Lancet Primary Care},
year = {2026},
volume = {2},
number = {8},
pages = {100201},
doi = {10.1016/j.lanprc.2026.100201}
}
EUVIMED